ACA Pharma Named Exclusive Distributor for Ferabright™ in Macau, Hong Kong, Singapore, Greater Bay Area & Mainland China

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop(R) System with Contrast Agents

(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain--the Swoop (R) system--today ...
Business Wire

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
The Robesonian

Roach: Man experiences symptoms of excess thyroid after MRI

You are also right that the iodine-containing dye from CT scans can precipitate hyperthyroidism in a person who is destined to get it. However, the risk of this occurring is low. There is no increased ...

Should you get a full-body MRI? Doctors warn benefits may not outweigh the hidden risks

Full-body MRI scans are gaining popularity, but doctors warn their benefits may not outweigh the risks for healthy, ...

ISMI Introduces a Radiologist-Led Full-Body MRI Program Focused on Diagnostic Clarity and Long-Term Health Planning

ISMI offers a radiologist-led Full-Body MRI in Montreal to identify life-saving findings, detect health risks, and support ...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.